Sakar Healthcare liquidity ratios

·UnclassifiedChart ›

Profitability Growth Credit Liquidity Working capital Dividend yield DuPont CAGR

Per cent unless marked ×

Tap a line for its trend	Last 12Mto Sep 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

9.42×	—	—	—	—	FY22 and earlierEvery year the company has filed comes with Alpha Plus.
1.28×	1.28×	1.40×	1.21×	1.03×
0.64×	0.64×	0.71×	0.74×	0.74×
0.0	50.1	0.1	0.3	3.5
40.7	30.9	25.5	12.6	1.4

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

SAKAR₹946.50

Sakar Healthcare Limited

· Unclassified

₹ CrorePeersMACPOWER SERVOTECH KAPSTON THEJOBETAMcap ₹2,106 Cr

Profitability Growth Credit Liquidity Working Capital Yield Analysis DuPont

Ratios — % unless marked × 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/09/2026
Altman Z-Score (Other Equity as RE)	—	—	—	—	9.42
Current Ratio	1.03	1.21	1.40	1.28	1.28
Quick Ratio	0.74	0.74	0.71	0.64	0.64
Cash, Equiv & ST Investments	3.5	0.3	0.1	50.1	0.0
Working Capital	1.4	12.6	25.5	30.9	40.7

No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.